Stock listing

CNSP Stock Price, News, Filings & Events — Cns Pharmaceuticals, Inc.

Selected listing: CNSP · NASDAQ · USD · US

This page tracks Cns Pharmaceuticals, Inc.'s CNSP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CNSP:NASDAQ. CNSP:NASDAQ is the stock-level entry point for investors researching Cns Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cns Pharmaceuticals, Inc. is a public company traded under the ticker CNSP in the American market. The company has a market capitalization of approximately $7.64 million. Cns Pharmaceuticals focuses on developing innovative therapies for the treatment of central nervous system cancers.

CNSP:NASDAQUSDUSUpdated September 11, 2026
Cns Pharmaceuticals, Inc. logo
Ticker
CNSP:NASDAQ
Asset type
Stock
Market cap
$8.5M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
NASDAQ
Currency
USD

Cns Pharmaceuticals, Inc. CNSP:NASDAQ stock context

This page tracks Cns Pharmaceuticals, Inc.'s CNSP:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CNSP:NASDAQ. CNSP:NASDAQ is the stock-level entry point for investors researching Cns Pharmaceuticals, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cns Pharmaceuticals, Inc. is a public company traded under the ticker CNSP in the American market. The company has a market capitalization of approximately $7.64 million. Cns Pharmaceuticals focuses on developing innovative therapies for the treatment of central nervous system cancers.

Latest news from Cns Pharmaceuticals, Inc.

All Cns Pharmaceuticals, Inc. news →

Research Cns Pharmaceuticals, Inc.

Alternate listings